Loading...

PM: Share Pullback Will Present Attractive Buying Opportunity Following Guidance Update

Published
16 Jul 24
Updated
05 Nov 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
18.4%
7D
1.1%

Author's Valuation

US$185.4420.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 05 Nov 25

Fair value Decreased 1.36%

Analysts have lowered their fair value price target for Philip Morris International from $188.00 to $185.44, citing slightly softer revenue growth and profit margin expectations. However, they note that the recent share pullback provides an attractive buying opportunity in light of overall positive business performance.

Shared on 21 Oct 25

Fair value Decreased 1.16%

Analysts Assess Philip Morris Pullback as Valuation Adjusts After Company Guidance and Dividend Boost

The analyst price target for Philip Morris International has been revised slightly downward from $190.20 to $188.00, as analysts cite moderating profit margin and revenue growth expectations. Analysts also note that recent share price weakness may present a buying opportunity.

Shared on 27 Aug 25

Fair value Increased 1.98%

Smoke-Free Alternatives Will Drive Global Opportunity In Emerging Markets

Analysts have raised their price target for Philip Morris International to $190.20, citing expectations for strong Q2 performance driven by growth in ZYN and IQOS, potential upward financial guidance revisions, and ongoing strength in both smoke-free and traditional products. Analyst Commentary Bullish analysts anticipate impressive Q2 delivery across all business segments, highlighting strong ZYN volumes and robust contributions from both IQOS and traditional combustible products.

Shared on 07 May 25

Fair value Increased 9.32%

Smoke-Free Alternatives Will Drive Global Opportunity In Emerging Markets

Shared on 30 Apr 25

Fair value Increased 8.90%

ZYN And IQOS Will Expand Global Market Opportunities

AnalystConsensusTarget has increased revenue growth from 7.0% to 7.9%.

Shared on 23 Apr 25

Fair value Decreased 0.32%

ZYN And IQOS Will Expand Global Market Opportunities

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 16 Apr 25

Fair value Increased 1.97%

ZYN And IQOS Will Expand Global Market Opportunities

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Increased 1.70%

ZYN And IQOS Will Expand Global Market Opportunities

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 1.23%

ZYN And IQOS Will Expand Global Market Opportunities

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

ZYN And IQOS Will Expand Global Market Opportunities

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

ZYN And IQOS Will Expand Global Market Opportunities

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Mar 25

Fair value Increased 0.45%

ZYN And IQOS Will Expand Global Market Opportunities

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 10 Mar 25

Fair value Decreased 19%

ZYN And IQOS Will Expand Global Market Opportunities

AnalystConsensusTarget has increased future PE multiple from 20.0x to 22.1x.